Swedish Orphan Biovitrum AB (BIOVF)
42.80
0.00 (0.00%)
USD |
OTCM |
Oct 12, 16:00
Swedish Orphan Biovitrum Price to Book Value : 3.404 for Oct. 12, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 12, 2026 | 3.404 |
| October 09, 2026 | 3.404 |
| October 08, 2026 | 3.404 |
| October 07, 2026 | 3.404 |
| October 06, 2026 | 3.404 |
| October 05, 2026 | 3.412 |
| October 02, 2026 | 3.412 |
| October 01, 2026 | 3.412 |
| September 30, 2026 | 3.412 |
| September 29, 2026 | 3.412 |
| September 28, 2026 | 3.828 |
| September 25, 2026 | 3.828 |
| September 24, 2026 | 3.828 |
| September 23, 2026 | 3.828 |
| September 22, 2026 | 3.828 |
| September 21, 2026 | 3.828 |
| September 18, 2026 | 3.828 |
| September 17, 2026 | 3.828 |
| September 16, 2026 | 3.828 |
| September 15, 2026 | 3.828 |
| September 14, 2026 | 3.828 |
| September 11, 2026 | 3.828 |
| September 10, 2026 | 3.828 |
| September 09, 2026 | 3.828 |
| September 08, 2026 | 3.828 |
| Date | Value |
|---|---|
| September 04, 2026 | 3.828 |
| September 03, 2026 | 3.828 |
| September 02, 2026 | 3.830 |
| September 01, 2026 | 3.830 |
| August 31, 2026 | 3.830 |
| August 28, 2026 | 3.830 |
| August 27, 2026 | 3.830 |
| August 26, 2026 | 3.830 |
| August 25, 2026 | 3.830 |
| August 24, 2026 | 3.830 |
| August 21, 2026 | 3.830 |
| August 20, 2026 | 3.830 |
| August 19, 2026 | 3.834 |
| August 18, 2026 | 3.834 |
| August 17, 2026 | 3.834 |
| August 14, 2026 | 3.834 |
| August 13, 2026 | 3.834 |
| August 12, 2026 | 3.834 |
| August 11, 2026 | 3.834 |
| August 10, 2026 | 3.834 |
| August 07, 2026 | 3.834 |
| August 06, 2026 | 3.834 |
| August 05, 2026 | 3.834 |
| August 04, 2026 | 3.834 |
| August 03, 2026 | 3.834 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Hansa Biopharma AB | -- |
| BioArctic AB | 12.52 |
| Diamyd Medical AB | 4.027 |
| BONESUPPORT HOLDING AB | 15.95 |
| BioInvent International AB | 6.600 |
Price to Book Value Related Metrics
| PE Ratio | 98.91 |
| PS Ratio | 4.555 |
| Price to Free Cash Flow | 29.81 |
| Price | 42.80 |
| Earnings Yield | 1.01% |
| Market Cap | 14.86B |
| Operating PE Ratio | 15.14 |
| Normalized PE Ratio | 21.49 |